title: Phase II study of D-verapamil and doxorubicin in patients with metastatic colorectal cancer.
authors.forename: W
authors.initials: W
authors.lastname: Scheithauer
authors.forename: G
authors.initials: G
authors.lastname: Kornek
authors.forename: J
authors.initials: J
authors.lastname: Kastner
authors.forename: M
authors.initials: M
authors.lastname: Raderer
authors.forename: G
authors.initials: G
authors.lastname: Locker
authors.forename: D
authors.initials: D
authors.lastname: Depisch
authors.forename: J
authors.initials: J
authors.lastname: Pidlich
authors.forename: C
authors.initials: C
authors.lastname: Tetzner
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D016896:Treatment Outcome; D014700:Verapamil / Q000008:administration & dosage
chemical_list: D004317:Doxorubicin; D014700:Verapamil